Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss

v3.7.0.1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Sales $ 87,520 $ 164,191
Cost of Sales 29,300 58,875
Gross Margin 58,220 105,316
Operating expenses    
Sales and marketing 445,525 82,198
Research and development 685,909 417,790
General and administrative 627,606 1,303,614
Share-based compensation expense (Notes 9(c) and 10) 251,048 219,248
Amortization (Note 3) 92,949 0
Depreciation (Note 6) 24,552 10,163
Total operating expenses 2,127,589 2,033,013
Other expenses (income)    
Foreign exchange 98,561 0
Interest expense (Note 7) 72,766 15,234
Other income (178) (11,218)
Change in fair value of warrant derivative liability (Note 11) 4,804 391,059
Total other expenses (income) 175,953 395,075
Net loss and comprehensive loss for the period $ (2,245,322) $ (2,322,772)
Loss per share - basic and diluted $ (0.02) $ (0.03)
Weighted average number of shares outstanding - basic and diluted 96,959,284 82,050,549